Non-Healing Wound Care Service Expands Before Medicare Rules Change In 2026

Share this news:

KureCare is expanding access to its wound care services ahead of Medicare policy changes that will restrict patient access to many products in January 2026. Remote patients are encouraged to seek treatment now, as the new guidelines will likely affect in-home treatment in rural areas.

-- A recent service expansion from KureCare comes as the window for the more generous Medicare guidelines begins to close. Experts say that the new policies in 2026 will delay access to many advanced options and may create barriers to treatment for homebound and remote patients, but access is still available for now.

Interested parties can learn more at https://www.curewounds.com

The U.S. Centers for Medicare and Medicaid Services has finalized new guidelines governing wound care that take effect January 1. These changes will require wound care patients to undergo four weeks of standard treatments and meet specific thresholds before qualifying for skin substitutes and other cutting-edge therapies.

KureCare representatives say wound patients still have time to be matched with healthcare providers who can treat them using the company's advanced products. Their regenerative biologics start working quickly, and many patients see complete healing within 42 days, according to KureCare data. While there are fewer than 42 days until the New Year, it's possible that Medicare may allow patients to continue treatment protocols that they've already started.

However, their team notes that patients who start home wound care services after January 1 are likely to face disproportionate impacts, according to recent reporting from HMP Global Learning Network.

Home care companies' operational costs—travel time, mileage, and limited portable equipment—will not be offset by the flat reimbursement model, straining resources for rural and homebound patients who cannot access in-person care. In the past, these populations depended upon in-home advanced therapies for wound closure, and ithout these products, they may deteriorate quickly at home and are at higher risk for infections and sepsis.

The upcoming Medicare changes respond to dramatic spending escalation on skin substitutes, which grew from $250 million to a projected $15.4 billion by the end of 2025, according to CMS data. The agency projects the new payment model will reduce Medicare spending on these products by nearly 90%.

However, experts worry these cuts will negatively affect patients by giving wounds more time to become infected, increasing the risk of amputation. Additionally, home care providers will likely be forced to reduce service radius, visit frequency, and case acceptance, which directly jeopardize access for the most vulnerable patients.

"Patients who establish care BEFORE January 1, 2026 may be protected under current coverage rules," a KureCare representative said. "If you wait until after the deadline, you may never have access to the treatments that could save your leg."

For more information, please visit https://curewounds.com

Contact Info:
Name: Kenton Gray
Email: Send Email
Organization: KureCare is a division of Veracor Group LLC
Address: 1150 NW 72ND AVE TOWER 1 STE 455 #20073 , Miami, FL 33126, United States
Website: https://curewounds.com

Release ID: 89179488